Bradley Champagne, MD

Appointed
2016

Education & Fellowships

Fellowship - Georgia Colorectal Clinic
Colorectal Surgery
Atlanta, GA USA
2006

Residency - Albany Medical Center
General Surgery
Albany, NY USA
2005

Medical Education - State University of New York Upstate Medical University
MD
Syracuse, NY USA
2000

Undergraduate - University of Scranton
Biology/History
Scranton, PA USA
1996

Additional Training

• Board Certified in General and Colorectal Surgery

Certifications

• Colon and Rectal Surgery

Specialty Interests

Colorectal Surgery

Awards & Honors

• Honors and Awards:Deans List 1992-1996
• Howard Hughes Research Grant 1994
• Howard Hughes Summer Stipend 1995
• Who's Who of American Universities 1993-1996
• Magna Cum Laude, Graduated with Honors in Biology 1996
• University of Scranton Annual Morris Albert Research Award 2003, 2004, 2005
• Albany Medical Center, Best Paper and Presentation "Outcome of Discharge within 48 hours of Laparoscopic Colorectal Surgery" ASCRS 2007
• Best Doctors 2011-2016
• Who's Who of Physicians 2011-2016
• America's Top Surgeons 2010-2016
• Cleveland Magazine Best Doctors 2011-2016
• Honorary Professor of Surgery: University of Lima 2012
• Midwest Surgical Association Best Paper Award for best oral presentation. Extraction site incision and incisional hernias after laparoscopic colorectal surgery: Should we be avoiding the midline? Champagne BJ et al
• ASCRS Traveling Fellow Award- HRA vs Expectant Management for AIN 3” Crawshaw B, Champagne BJ et al. ASCRS 2014- Hollywood, Florida, Best Manuscript.

See publications for Bradley Champagne, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/30/2021, Dr. Champagne has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.